{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/281656721"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "The report notes that in the 2012 budget process, some individual global health R&D programs experienced reductions, alongside cuts to what are known as product development partnerships (PDPs)--relatively new and innovative types of public-private partnerships focused on developing drugs, vaccines, diagnostics, and other products specifically for patients in low-income countries." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "eurekalert.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/217189638"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/281656721"] } } }
